• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
Generic Name: 1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio] butadiene
Date Designated: 08/03/2017
Orphan Designation: Treatment of subarachnoid hemorrhage (SAH)
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Edvince AB
Medicon Village
Scheelevägen 2
Lund, Skåne län
Sweden

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-